Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel H Mathalon

Showing results (291-300 of 435) with videos related to

Pageof 44
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 11, 2017
The Role of microRNA Expression in Cortical Development During Conversion to PsychosisAmanda B Zheutlin, Clark D Jeffries, Diana O Perkins, et al.
Early Intervention in Psychiatry|October 27, 2018
Tobacco use and psychosis risk in persons at clinical high riskHeather B Ward, Michael T Lawson, Jean Addington, et al.
Schizophrenia Research|April 9, 2026
Social withdrawal and hippocampal volume among adolescents at clinical high risk for psychosis and healthy comparisons: The moderating role of neighborhood residential stabilityBenson S Ku, Ella J Arrant, Qingyue E Yuan, et al.
Medrxiv : the Preprint Server for Health Sciences|April 3, 2026
Longitudinal Relationships Between Cannabis and Tobacco Use and Symptom Severity in Individuals at Clinical High Risk for PsychosisYunong Bai, Simon Vandekar, Brandee Feola, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|March 9, 2017
Supervised multimodal fusion and its application in searching joint neuromarkers of working memory deficits in schizophreniaShile Qi, Vince D Calhoun, Theo G M van Erp, et al.
The American Journal of Psychiatry|November 13, 2019
Polygenic Risk Score Contribution to Psychosis Prediction in a Target Population of Persons at Clinical High RiskDiana O Perkins, Loes Olde Loohuis, Jenna Barbee, et al.
The American Journal of Psychiatry|July 2, 2016
An Individualized Risk Calculator for Research in Prodromal PsychosisTyrone D Cannon, Changhong Yu, Jean Addington, et al.
Frontiers in Psychiatry|June 9, 2023
The impact of early factors on persistent negative symptoms in youth at clinical high risk for psychosisDaniel J Devoe, Lu Lui, Tyrone D Cannon, et al.
Schizophrenia Research|December 3, 2014
Stress exposure and sensitivity in the clinical high-risk syndrome: initial findings from the North American Prodrome Longitudinal Study (NAPLS)Hanan D Trotman, Carrie W Holtzman, Elaine F Walker, et al.
Schizophrenia Research|June 29, 2026
Converting negative symptom dimension scores across SANS and PANSSS O M Vijayakumar Kamalakannan, Jaylen Lee, Annalisa Lella, et al.
Pageof 44

Showing results (291-300 of 435) with videos related to

Sort By:
Pageof 44
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 11, 2017
The Role of microRNA Expression in Cortical Development During Conversion to PsychosisAmanda B Zheutlin, Clark D Jeffries, Diana O Perkins, et al.
Early Intervention in Psychiatry|October 27, 2018
Tobacco use and psychosis risk in persons at clinical high riskHeather B Ward, Michael T Lawson, Jean Addington, et al.
Schizophrenia Research|April 9, 2026
Social withdrawal and hippocampal volume among adolescents at clinical high risk for psychosis and healthy comparisons: The moderating role of neighborhood residential stabilityBenson S Ku, Ella J Arrant, Qingyue E Yuan, et al.
Medrxiv : the Preprint Server for Health Sciences|April 3, 2026
Longitudinal Relationships Between Cannabis and Tobacco Use and Symptom Severity in Individuals at Clinical High Risk for PsychosisYunong Bai, Simon Vandekar, Brandee Feola, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|March 9, 2017
Supervised multimodal fusion and its application in searching joint neuromarkers of working memory deficits in schizophreniaShile Qi, Vince D Calhoun, Theo G M van Erp, et al.
The American Journal of Psychiatry|November 13, 2019
Polygenic Risk Score Contribution to Psychosis Prediction in a Target Population of Persons at Clinical High RiskDiana O Perkins, Loes Olde Loohuis, Jenna Barbee, et al.
The American Journal of Psychiatry|July 2, 2016
An Individualized Risk Calculator for Research in Prodromal PsychosisTyrone D Cannon, Changhong Yu, Jean Addington, et al.
Frontiers in Psychiatry|June 9, 2023
The impact of early factors on persistent negative symptoms in youth at clinical high risk for psychosisDaniel J Devoe, Lu Lui, Tyrone D Cannon, et al.
Schizophrenia Research|December 3, 2014
Stress exposure and sensitivity in the clinical high-risk syndrome: initial findings from the North American Prodrome Longitudinal Study (NAPLS)Hanan D Trotman, Carrie W Holtzman, Elaine F Walker, et al.
Schizophrenia Research|June 29, 2026
Converting negative symptom dimension scores across SANS and PANSSS O M Vijayakumar Kamalakannan, Jaylen Lee, Annalisa Lella, et al.
Pageof 44